Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.

Transplantation - 27 Jul 2011

Myhre Hans-Arne, Haug Dorenberg Dagny, Kristiansen Knut Ivan, Rollag Halvor, Leivestad Torbjørn, Asberg Anders, Hartmann Anders

Abstract excerpt

BACKGROUND: Cytomegalovirus (CMV) infections in kidney transplant recipients are in most cases successfully treated with oral valganciclovir (VGCV). However, in a few percent of patients, mutations in the UL 97 or UL 54 gene lead to drug resistance. METHODS: We investigated the incidence and outcomes of ganciclovir-resistant CMV viremia in all 1244 kidney recipients transplanted at our center from 2004 through...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus
Share to Cytomegalovirus Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Foscarnet

Share to Ganciclovir

Share to Kidney Transplantation

Share to Norway

Share to Phosphotransferases (Alcohol Group Acceptor)

Share to Transplantation

Source

Identifiers

PMID: 21685829
DOI: 10.1097/TP.0b013e31821fad25

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients.PMID 21685829Read ↗

Resistant Cytomegalovirus Infection After Renal Transplantation: Literature Review.Semantic proximity Read ↗

Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis.Semantic proximity Read ↗

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.Semantic proximity Read ↗

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.Semantic proximity Read ↗

Cytomegalovirus Antiviral Resistance Among Kidney Transplant Recipients in a Phase 3 Trial of Letermovir vs Valganciclovir Prophylaxis.Semantic proximity Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.Semantic proximity Read ↗

Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.Semantic proximity Read ↗

The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.Semantic proximity Read ↗

Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation.Semantic proximity Read ↗

Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in Tehran.Semantic proximity Read ↗

A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.